Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №10 (2025) > Metabolic endotoxemia in diabetes mellitus type 1 & 2 patients

Metabolic endotoxemia in diabetes mellitus type 1 & 2 patients

Vladimir A. Beloglazov , Aleksandr A. Gorlov , Igor A. Yatskov , Elizaveta S. Ageeva , Irina N. Repinskaya , Emilia R. Zagidullina

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Diabetes mellitus (DM) – is a systemic endocrinologic disorder linked to impaired processing of glucose either due to insufficient insulin levels, insluin resistance or excessive dietary carbs. DM puts a significant strain on a healthcare whereas patients with DM have much lower quality of life and imposing list of comorbidities and complications. Sustained long-term inflammation is a key driving factor that should be adressed while treating DM. Dietary factors, obesity, gut dysbiosis all contribute to higher levels of inflammation in DM patients. Endotoxemia (a condition known to reflect the impaired proper gut barrier function) plays an important role in the development of inflammatory state seen in DM patients. 
Aim. To evaluate the role of endotoxinemia in DM in the development of systemic inflammation.
Materials and methods. Our prospective cross-sectional study involved 177 patients with verified diagnoses of type 1 diabetes mellitus (insulin-dependent) (DM1) (n=90), type 2 diabetes mellitus (non-insulin-dependent) (DM2) (n=45) and a control group (practically healthy) (n=42). Correlation analysis was used to establish the relationship between HBA1c and sCD14 as a marker of endotoxemia.
Results. Correlation analysis of the DM2 group showed associations of sCD14 with HbA1c (correlation strength 0.404), zonulin (0.398). Zonulin also correlated with endothelin-1 levels and body mass index, two traditional pro-inflammatory associations (0.312 and 0.343, respectively). LSB correlated with VEGF (0.620) and CRP (0.430). The same CRP correlated with such classical “proxies” of chronic systemic inflammation as LDL (0.333) and HbA1c (0.430).
Conclusions. Endotoxinemia in DM2 is metabolic in nature, while in DM1 it is more likely to be “autoimmune”, that is, more mediated through zonulin than through chronic inflammation observed in patients with DM2. For example, this is additionally confirmed by a higher incidence of celiac disease among DM1 patients. The role of endotoxinemia in patients with type 2 and type 1 diabetes remains a poorly understood issue.
Keywords: diabetes mellitus, metabolic endotoxemia, lipopolysaccharide, LPS binding protein.

About the Author

Vladimir A. Beloglazov 1 , Aleksandr A. Gorlov 1 , Igor A. Yatskov 1 , Elizaveta S. Ageeva 1 , Irina N. Repinskaya 1 , Emilia R. Zagidullina 1

1 Georgievsky Medical Institute, Vernadsky Crimean Federal University, Simferopol, Russia

References

1. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104-23. DOI: 10.14341/DM13035
Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes Mellitus 2023;26(2):104-23. DOI: 10.14341/DM13035 (in Russian).
2. Bodke H, Wagh V, Kakar G. Diabetes Mellitus and Prevalence of Other Comorbid Conditions: A Systematic Review. Cureus 2023 Nov 24;15(11):e49374.
3. Яковлев М.Ю. Системная эндотоксинемия. М.: Наука; 2021. 184 с.
Yakovlev M.Yu. Systemic endotoxemia. Moscow: Nauka; 2021. 184 p. (in Russian).
4. Khalil M., Addai Ali H., Alhilo M. Role of Zonulin level as new metabolic biomarker in diabetes mellitus patients and associated complications. AIP Conf Proc 2022 Jan 11;2386(1):030013.
5. Pellicano C, Oliva A, Colalillo A et al. Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis. Clin Exp Med 2024 Sep 19;24(1):225. 
6. Haskey N, Eisele M, Bruno A et al. Biomarkers of Intestinal Permeability Are Influenced by Diet in Patients with Ulcerative Colitis-An Exploratory Study. Diagnostics (Basel) 2024 Nov 22;14(23):2629. 
7. Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016 Oct 21;4(4):e1251384. 
8. Zihni C, Mills C, Matter K et al. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17:564-80. 
9. Fernández-Valero A, Peña-Montero N, Lima-Rubio F et al. Changes in Oxidative Stress and Intestinal Permeability during Pregnancy in Women with Gestational Diabetes Mellitus Treated with Metformin or Insulin and Healthy Controls: A Randomized Controlled Trial. Antioxidants (Basel) 2023 Nov 8;12(11):1981. 
10. Babu SN, Govindarajan S, Vijayalakshmi MA, Noor A. Role of zonulin and GLP-1/DPP-IV in alleviation of diabetes mellitus by peptide/polypeptide fraction of Aloe vera in streptozotocin- induced diabetic wistar rats. J Ethnopharmacol 2021 May 23;272:113949. 
11. Sapone A, de Magistris L, Pietzak M et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006 May;55(5):1443-9. 
12. Wood Heickman LK, DeBoer MD, Fasano A. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev 2020 Jul;36(5):e3309. DOI: 10.1002/dmrr.3309. Epub 2020 Mar 31. 

For citation:Beloglazov V.A., Gorlov A.A., Yatskov I.A., Ageeva E.S., Repinskaya I.N., Zagidullina E.R. Metabolic endotoxemia in diabetes mellitus type 1 & 2 patients. Clinical review for general practice. 2025; 6 (10): 32–38 (In Russ.). DOI: 10.47407/kr2025.6.10.00690


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru